These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38889447)

  • 1. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.
    Modi A; Purohit P; Roy D; Vishnoi JR; Pareek P; Elhence P; Singh P; Sharma S; Sharma P; Misra S
    Mol Biol Rep; 2022 Apr; 49(4):2877-2888. PubMed ID: 35066766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
    Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
    Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
    Song KH; Park MS; Nandu TS; Gadad S; Kim SC; Kim MY
    Nat Commun; 2016 Dec; 7():13796. PubMed ID: 27982029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.
    Shen W; Zhang X; Tang J; Zhang Z; Du R; Luo D; Liu X; Xia Y; Li Y; Wang S; Yan S; Yang W; Xiang R; Luo N; Luo Y; Li J
    Theranostics; 2021; 11(5):2297-2317. PubMed ID: 33500726
    [No Abstract]   [Full Text] [Related]  

  • 9. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
    Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
    Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
    Kimura R; Yoshimaru T; Matsushita Y; Matsuo T; Ono M; Park JH; Sasa M; Miyoshi Y; Nakamura Y; Katagiri T
    Int J Oncol; 2020 Feb; 56(2):581-595. PubMed ID: 31894262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
    Wu J; Chen X; Bao Q; Duan R; Jin Y; Shui Y; Yao B; Lu X; Wang Y; Cui H; Li L; Yuan H; Ma C
    Cell Physiol Biochem; 2017; 44(3):998-1010. PubMed ID: 29227978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
    Cheng S; Huang Y; Lou C; He Y; Zhang Y; Zhang Q
    Cancer Biol Ther; 2019; 20(3):328-337. PubMed ID: 30336071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity.
    Li P; Feng C; Chen H; Jiang Y; Cao F; Liu J; Liu P
    J Cell Mol Med; 2018 Jul; 22(7):3423-3433. PubMed ID: 29602199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.